<DOC>
	<DOCNO>NCT00965497</DOCNO>
	<brief_summary>The purpose study see escitalopram ( Lexapro ) improve symptoms major depressive disorder patient ALS MS .</brief_summary>
	<brief_title>Escitalopram ( Lexapro ) Depression MS ALS</brief_title>
	<detailed_description>This eight-week study aim assess effectiveness tolerability escitalopram improve symptom Major Depression patient Amyotrophic Lateral Sclerosis ( ALS ) Multiple Sclerosis ( MS ) measure HAM-D . In addition , study ass improvement quality life patient Major Depression ALS MS .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Patients 18 70 year age document ALS MS , DSMIV episode nonpsychotic Major Depression , â‰¥14 score 17item HAMD , Ability give inform consent . History psychotic disorder , Psychotic depression , Bipolar depression , Suicide risk , History substance abuse previous 6 month , History unstable medical disorder , Pregnancy plan pregnancy , Severity ALS MS limit participate study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>ALS</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>MS</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>antidepressant</keyword>
	<keyword>Escitalopram</keyword>
	<keyword>Lexapro</keyword>
</DOC>